Home › Ewing Sarcoma › Tennessee › Memphis
Ewing Sarcoma clinical trials in Memphis, TN
7 studies for Ewing Sarcoma are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Saint Jude Children's Research Hospital, Memphis
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Recruiting
- St. Jude Children's Research Hospital, Memphis
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- St. Jude Children's Research Hospital, Memphis
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
RecruitingPhase 1/2
- St. Jude Children's Research Hospital, Memphis
Molecular Analysis Of Solid Tumors
RecruitingObservational study
- St. Jude Children's Research Hospital, Memphis
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Philadelphia, PA7 studies
- Aurora, CO6 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Washington, DC6 studies
- Birmingham, AL5 studies
- Atlanta, GA5 studies
- Cincinnati, OH4 studies
- Phoenix, AZ4 studies
- Columbus, OH4 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.